Los Angeles Capital Management LLC Glaukos Corp Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$69.23 - $79.09 $150,644 - $172,099	-2,176 Reduced 23.21%	7,200 $541,000
Q2 2023 Aug 03, 2023	BUY	$45.44 - $71.21 $426,045 - $667,664	9,376 New	9,376 $667,000
Q4 2019 Feb 07, 2020	SELL	$54.18 - $65.64 $464,322 - $562,534	-8,570 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$58.58 - $83.91 $231,391 - $331,444	3,950 Added 85.5%	8,570 $536,000
Q1 2019 Apr 25, 2019	BUY	$50.75 - $80.54 $234,465 - $372,094	4,620 New	4,620 $362,000
Q4 2017 Feb 05, 2018	SELL	$24.5 - $36.01 $305,760 - $449,404	-12,480 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$31.26 - $42.03 $192,561 - $258,904	6,160 Added 97.47%	12,480 $412,000
Q2 2017 Aug 09, 2017	BUY	N/A	6,320	6,320 $262,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.